News Column

Envision Healthcare Holdings Gears Up for Secondary Offering of Common Stock

January 27, 2014

Envision Healthcare Holdings, Inc. announced that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to a proposed secondary offering of 27.5 million shares of its common stock by certain stockholders of the Company. In a release, the Company said that investment funds sponsored by, or affiliated with, Clayton, Dubilier & Rice and certain executive officers and employees of the Company will be the selling stockholders. In connection with the offering, the selling stockholders will grant the underwriters an option to purchase up to 4.125 million additional shares of common stock. The Company will not receive any proceeds from the proposed secondary offering. The proposed secondary offering will be made only by means of a prospectus. Goldman, Sachs & Co. , Barclays , BofA Merrill Lynch and Citigroup are serving as lead joint book-running managers and as representatives of the underwriters for the proposed secondary offering. When available, copies of the preliminary prospectus relating to the proposed secondary offering may be obtained from Goldman, Sachs & Co. ((Comments on this story may be sent to health@closeupmedia.com ))


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Health & Beauty Close - Up


Story Tools